Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Proposed Ministerial Reliance Order Would Allow Health Canada To Rely On Decisions Of Foreign Trusted Regulators

On December 19, 2025, the Minister of Health announced the launch of consultations on two key regulatory initiatives referenced in Health Canada's Red Tape Review report...

Canada Healthcare

SB

Smart & Biggar

Revue de l'année 2025 en droit des brevets au Canada

L'année 2025 a été marquée par des changements législatifs importants et par l'audience tant attendue concernant la brevetabilité des méthodes de traitement médical devant la Cour suprême du Canada.

SB

Smart & Biggar

Zero-Rated Or Taxable Food & Drinks?

The supplies of food and beverages that are for human consumption are generally zero-rated for GST/HST purposes in Canada – meaning that a 0% rate of tax applies...

MK

Millar Kreklewetz

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Voici les articles les plus lus de la rubrique Mise à jour en PI Rx en 2025...

Canada Healthcare

SB

Smart & Biggar

Canadian Trademark Law Year In Review 2025: Notable Decisions And Updates

C

Cassels

The Canada Mutual Recognition Agreement – A Two-Way Street To The Market

FR

Fillmore Riley

Double brevet et demandes divisionnaires au Canada : des stratégies évolutives pour les demandeurs

SB

Smart & Biggar

Service Of Process: More Than A Formality

Canada Litigation

C

Cassels

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Les faits saillants de 2025 au Canada en matière de PI en sciences de la vie et de droit réglementaire

Canada Healthcare

SB

Smart & Biggar

2025 Highlights In Canadian Life Sciences IP And Regulatory Law

Canada Healthcare

SB

Smart & Biggar

Class Action Pursued Concerning Safety Defects With GLP-1 Drugs Mounjaro, Trulicity, & Zepbound

Canada Litigation

SL

Siskinds LLP

Federal Court Of Appeal Confirms BYOOVIZ Is Confusing With Novartis' BEOVU Trademark

SB

Smart & Biggar

Santé Canada lance une consultation sur deux documents d'ébauche de lignes directrices sur les conditions pour les médicaments à usage humain et vétérinaire ainsi que les présentations de drogues basées sur des preuves prometteuses d'efficacité clinique

Canada Healthcare

SB

Smart & Biggar

11 Tax Changes To The Income Tax Act (ITA) In 2026 And Beyond That Canadian Taxpayers, Canadian Businesses Need To Know About

RS

Rotfleisch & Samulovitch P.C.

Regulatory Incentives For Ontario Distributors To Encourage DER Integration Through Non-wires Solutions

TL

Torys LLP

Province Launches First IESO-led Competitive Process For Underwater High Voltage Transmission Line In Toronto

MT

McCarthy Tétrault LLP

After The Surge: Understanding The GTA's Housing Market Decline

Canada Real Estate

AB

Aird & Berlis LLP

Expropriation Law: Important Notice For Homeowners

Canada Real Estate

M

McQuarrie

Proposal For Modernizing Clinical Trial Framework Aims To Improve Access To New And Innovative Therapies In Canada

On December 20, 2025, Health Canada launched a consultation on modernizing the framework for clinical trials involving drugs for human use, including pharmaceuticals, biologics, radiopharmaceuticals, and cannabis.

Canada Healthcare

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Le 20 décembre 2025, Santé Canada a lancé une consultation sur la modernisation du cadre des essais cliniques visant les médicaments destinés à l'usage des humains...

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Patients who have been diagnosed with tumours or cancers after using pharmaceutical or health products may be able to pursue legal claims against manufacturers when credible scientific...

Canada Healthcare

SL

Siskinds LLP

Legislative Update Report No. 2025-24 Le Bulletin D'actualités Législatives

Osler's Legislative Update is a bi-weekly listing of new legislation. This issue covers legislation for the period 12/12 to 12/24.

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Naming Natural Health Products: Branding In A Grey Zone

Canada Healthcare

ML

McMillan LLP

Liability Of Police Chiefs & Police Boards For Officer Misconduct: Rivard V. Ontario, 2025 ONCA 100

Canada Litigation

AH

Alexander Holburn Beaudin + Lang LLP

Health Canada Consultation On Two Draft Guidance Documents On Terms And Conditions For Human And Veterinary Drugs And Drug Submissions Based On Promising Evidence Of Clinical Efficacy

Canada Healthcare

SB

Smart & Biggar

Supreme Court Of Canada Affirms Immunity From Arrest In S.4.1(2) Of The Controlled Drugs And Substances Act

Canada Healthcare

AH

Alexander Holburn Beaudin + Lang LLP

British Columbia Enacts Bill 24 To Recoup Vaping-related Health Care Costs

Canada Healthcare

TL

Torys LLP

Federal Court Of Appeal Clarifies Role Of Patients When Assessing Confusion For Pharmaceutical Trademarks

OW

Oyen Wiggs Green & Mutala LLP

How Is AI Transforming The Life Sciences Industry?

Canada Technology

TL

Torys LLP

Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes

MT

McCarthy Tétrault LLP

What You Should Know About The Freestyle Libre 3 Recall

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

How Is AI Transforming The Life Sciences Industry?

Stakeholders are grappling with the numerous opportunities and risks presented by the convergence of artificial intelligence and tools designed for the development of novel therapeutics and the delivery of health care.

Canada Technology

TL

Torys LLP

Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes

À compter du 1er janvier 2026, le Conseil d'examen du prix des médicaments brevetés (CEPMB) mettra en œuvre de nouvelles Lignes directrices pour la surveillance des prix des médicaments brevetés au Canada.

MT

McCarthy Tétrault LLP

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Despite recent pullbacks in biotechnology and life sciences venture capital ("VC") funding in Canada, a more in-depth analysis reveals strong indicators of investment demand...

Canada Healthcare

MT

McCarthy Tétrault LLP

Taking Action On Food Insecurity

Canada Healthcare

ML

McMillan LLP

Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews

Health Canada and the U.S. Food and Drug Administration (FDA) have created a program to support the establishment of a Request for Information Sharing (RIS) program...

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Releases New Resource And Data On Drug Approval And Reimbursement Pathway

Canada's Drug Agency (CDA-AMC) published data on Canada's drug system as part of the Data Systems and Analytics program.

SB

Smart & Biggar

Final Changes To Quebec's Exceptional Patient Measure To Come Into Effect

As previously indicated in our July 2025 bulletin, the Régie de l'assurance maladie du Québec ("RAMQ") has been implementing significant reforms to the Exceptional Patient Measure (in French, la mesure du patient d'exception, "PE Measure").

Canada Healthcare

F

Fasken

How To Find The Risks Linked To Your Prescriptions

Does Mounjaro lead to stomach paralysis? What risks are associated with Xarelto blood thinner? Does Dupixent cause cancer?

Canada Healthcare

SL

Siskinds LLP

Tis The Season For Holiday Parties At Work And At Home

Canada Litigation

GP

Gluckstein Lawyers

St. Catharines v. Al-Kadhee – Closing Order Application Unburdens Community Of Problem House

Canada Real Estate

BA

Boghosian + Allen

The Rise Of Unionization In Canada: Strategies For Employers In A Post-pandemic World

Canada Employment

MT

Miller Thomson LLP

The BC Supreme Court Reinforces A Plaintiff's Duty To Exercise A Modicum Of Awareness For Their Own Safety In Petrunia v. Pensionfund Realty Limited, 2025 BCSC 2345

Canada Litigation

CC

CLC (Canadian Litigation Counsel)

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

Canada Healthcare

SB

Smart & Biggar

December 2025 Rosen Sunshine Newsletter

Canada Healthcare

RS

Rosen Sunshine LLP

L'Ontario propose de réglementer les réseaux de fournisseurs privilégiés entre assureurs et pharmacies

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

L'Ontario propose des mesures législatives pour encadrer les réseaux de fournisseurs privilégiés

Canada Healthcare

SB

Smart & Biggar

Branding Medical Devices: Balancing Brand Protection And Regulation

Canada Healthcare

ML

McMillan LLP

Ontario proposes legislation to regulate preferred provider networks

Canada Healthcare

SB

Smart & Biggar

PCPA Introducing Revisions To Pathway For Non-complex Drug Negotiations

Canada Healthcare

SB

Smart & Biggar

New Food Labelling Rules Incoming

Canada International

MK

Millar Kreklewetz

Ozempic, A Diabetes Drug Linked To Gastrointestinal Issues And Vision Loss, Approved To Treat Kidney Issues

Canada Healthcare

SL

Siskinds LLP

Changing The Script: Ontario Proposes To Regulate Preferred Provider Networks Between Insurers And Pharmacies

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Image de marque fondée sur l'identité canadienne : qu'est-ce que ça implique vraiment?

SB

Smart & Biggar

See more

Latest Videos

See more

Pricing And Reimbursement: Federal Drug Price Control

TL

Torys LLP

Nutrition Tips & Advice During COVID-19 (Video)

GW

Gowling WLG

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

What Are The Challenges And Opportunities In Ontario's Budding Cannabis Retail Market? (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Two: Weed Growth (Video)

D

Dentons Canada LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More